Literature DB >> 25795153

Current state of continuous renal replacement therapy for acute kidney injury in Japanese intensive care units in 2011: analysis of a national administrative database.

Masao Iwagami1, Hideo Yasunaga2, Eisei Noiri3, Hiromasa Horiguchi4, Kiyohide Fushimi5, Takehiro Matsubara6, Naoki Yahagi6, Masaomi Nangaku3, Kent Doi7.   

Abstract

BACKGROUND: Nationwide data for the prevalence and outcomes of patients receiving continuous renal replacement therapy (CRRT) in intensive care units (ICUs) are scarce. This study assessed the status of CRRT in Japanese ICUs using a nationwide administrative claim database.
METHODS: Data were extracted from the Japanese Diagnosis Procedure Combination database for 2011. From a cohort of critically ill patients aged 12 years or older who were admitted to ICUs for 3 days or longer, acute kidney injury (AKI) patients treated with CRRT were identified. The period prevalence of CRRT and in-hospital mortality were calculated. Logistic regression analysis identified factors associated with in-hospital mortality.
RESULTS: Of 165 815 ICU patients, 6478 (3.9%) received CRRT for AKI. The most frequent admission diagnosis category was diseases of the circulatory system (n = 3074). The overall in-hospital mortality rate of the CRRT-treated AKI patients was 50.6%. Clustering patients into four groups by background revealed the lowest in-hospital mortality rate of 41.5% for the cardiovascular surgery group (n = 1043) compared with 53.5% for the nonsurgical cardiovascular group (n = 2031), 51.7% for the sepsis group (n = 1863) and 51.6% for other cases (n = 1541). Multiple logistic regression analysis showed a significant association of these four group classifications with in-hospital mortality in addition to age, hospital characteristics (type and volume), time from hospital admission to CRRT initiation and interventions performed on the day of CRRT initiation.
CONCLUSIONS: Using a large Japanese nationwide database, this study revealed remarkably high in-hospital mortality of CRRT-treated AKI patients, although the period prevalence of CRRT for AKI in ICUs was low.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  acute kidney injury; cardiorenal syndrome; cardiovascular surgery; continuous renal replacement therapy; sepsis

Mesh:

Year:  2015        PMID: 25795153     DOI: 10.1093/ndt/gfv069

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  18 in total

1.  Associations of Polyethylenimine-Coated AN69ST Membrane in Continuous Renal Replacement Therapy with the Intensive Care Outcomes: Observations from a Claims Database from Japan.

Authors:  Kent Doi; Masao Iwagami; Emiko Yoshida; Mark R Marshall
Journal:  Blood Purif       Date:  2017-06-14       Impact factor: 2.614

2.  Association between intravenous contrast media exposure and non-recovery from dialysis-requiring septic acute kidney injury: a nationwide observational study.

Authors:  Yoshihisa Miyamoto; Masao Iwagami; Shotaro Aso; Hideo Yasunaga; Hiroki Matsui; Kiyohide Fushimi; Yoshifumi Hamasaki; Masaomi Nangaku; Kent Doi
Journal:  Intensive Care Med       Date:  2019-08-26       Impact factor: 17.440

3.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

4.  Global Perspectives in Acute Kidney Injury: Japan.

Authors:  Hiroyuki Yamada; Motoko Yanagita
Journal:  Kidney360       Date:  2022-03-29

Review 5.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

6.  Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.

Authors:  Hiraku Tsujimoto; Yasushi Tsujimoto; Yukihiko Nakata; Tomoko Fujii; Sei Takahashi; Mai Akazawa; Yuki Kataoka
Journal:  Cochrane Database Syst Rev       Date:  2020-03-13

7.  Short- and Long-Term Mortality Rates of Elderly Acute Kidney Injury Patients Who Underwent Continuous Renal Replacement Therapy.

Authors:  Harin Rhee; Keum Sook Jang; Jong Man Park; Jin Suk Kang; Na Kyoung Hwang; Il Young Kim; Sang Heon Song; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

8.  The role of the specialized team in the operation of continuous renal replacement therapy: a single-center experience.

Authors:  Harin Rhee; Gum Sook Jang; Miyeun Han; In Seong Park; Il Young Kim; Sang Heon Song; Eun Young Seong; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak
Journal:  BMC Nephrol       Date:  2017-11-13       Impact factor: 2.388

9.  Outcomes of patients with acute kidney injury with regard to time of initiation and modality of renal replacement therapy - first data from the Silesian Registry of Intensive Care Units.

Authors:  Piotr Czempik; Daniel Cieśla; Piotr Knapik; Łukasz Krzych
Journal:  Kardiochir Torakochirurgia Pol       Date:  2016-06-30

10.  Response to different furosemide doses predicts AKI progression in ICU patients with elevated plasma NGAL levels.

Authors:  Ryo Matsuura; Yohei Komaru; Yoshihisa Miyamoto; Teruhiko Yoshida; Kohei Yoshimoto; Rei Isshiki; Kengo Mayumi; Tetsushi Yamashita; Yoshifumi Hamasaki; Masaomi Nangaku; Eisei Noiri; Naoto Morimura; Kent Doi
Journal:  Ann Intensive Care       Date:  2018-01-17       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.